List of insiders holdings for Kalaris Therapeutics Inc.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
# | Insider Holder Name | Report Date Time |
Shares Owned Directly Indirectly |
Total Shares Owned |
Filing |
1 | F2 MG Ltd Globeways Holdings Ltd F2 - TPO Investments LLC F2 MC LLC F2 Capital I 2020 F2 Bioscience AV 2022 LLC Globeways Holdings II Ltd Director 10% Owner |
2022-08-05 16:17:00 | 26,578,054 0 |
26,578,054 | Form 13D |
2 | GADICKE ANSBERT Director 10% Owner |
2022-08-01 16:34:52 | 30,197 16,674,766 |
16,704,963 | Form 4 |
3 | ElevateBio LLC Director 10% Owner |
2022-08-05 16:16:01 | 16,674,766 0 |
16,674,766 | Form 13D |
4 | Samsara BioCapital GP LLC Samsara BioCapital L.P. 10% Owner |
2025-03-25 19:40:09 | 11,448,081 0 |
11,448,081 | Form 13D |
5 | Wilson John Robert Director |
2024-01-09 12:32:15 | 5,355,877 0 |
5,355,877 | Form 13G |
6 | Leen Ann M. Chief Scientific Officer |
2023-02-03 17:00:29 | 1,356,288 2,288,154 |
3,644,442 | Form 4 |
7 | Vera Juan Director |
2024-06-07 16:05:08 | 2,409,928 0 |
2,409,928 | Form 4 |
8 | Redmile Group LLC Green Jeremy 10% Owner |
2020-08-05 16:31:28 | 0 823,371 |
823,371 | Form 4 |
9 | Sinha Vikas See Remarks 10% Owner |
2025-02-24 16:15:10 | 49,129 724,989 |
774,118 | Form 4 |
10 | Brainard Diana Chief Executive Officer |
2024-11-20 16:15:03 | 723,363 0 |
723,363 | Form 4 |
11 | GILEAD SCIENCES INC. 10% Owner |
2025-03-20 16:32:25 | 723,273 0 |
723,273 | Form 13G |
12 | Melian Agustin Chief Medical Officer |
2021-10-05 21:05:54 | 453,529 0 |
453,529 | Form 4 |
13 | Piccina Cintia Chief Commercial Officer |
2023-07-05 17:00:20 | 420,000 0 |
420,000 | Form 4 |
14 | VAN BEEK JEROEN B Chief Commercial Officer |
2022-11-18 16:05:18 | 333,726 0 |
333,726 | Form 4 |
15 | Oxtoby Andrew See Remarks |
2025-04-11 16:55:49 | 287,000 0 |
287,000 | Form 4 |
16 | Brenner Malcolm Director |
2024-06-07 16:05:10 | 100,197 163,732 |
263,929 | Form 4 |
17 | Feinsod Matthew Chief Medical Officer |
2025-04-11 16:52:08 | 171,551 0 |
171,551 | Form 4 |
18 | Atillasoy Ercem See Remarks |
2022-10-26 16:15:45 | 131,372 0 |
131,372 | Form 4/A |
19 | Bornstein Jeffrey S Director |
2024-06-07 16:05:10 | 110,197 0 |
110,197 | Form 4 |
20 | Adams Derek N. Director |
2024-06-07 16:05:11 | 70,000 0 |
70,000 | Form 4 |
21 | Tomasello Shawn Director |
2024-06-07 16:05:07 | 70,000 0 |
70,000 | Form 4 |
22 | Hagen Brett R Chief Accounting Officer |
2025-04-11 17:27:32 | 50,262 0 |
50,262 | Form 4 |
23 | Miller Edward General Counsel |
2025-02-24 16:15:05 | 6,517 15,058 |
21,575 | Form 4 |
24 | Hallal David Director |
2025-04-11 16:41:02 | 18,000 0 |
18,000 | Form 4 |
25 | PATTERSON LEONE D Director |
2025-04-11 16:48:34 | 18,000 0 |
18,000 | Form 4 |
26 | ADAMIS ANTHONY P Director |
2025-04-11 16:52:28 | 18,000 0 |
18,000 | Form 4 |
27 | Ferrara Napoleone Director |
2025-04-11 17:03:27 | 18,000 0 |
18,000 | Form 4 |
28 | AKKARAJU SRINIVAS Director 10% Owner |
2025-04-11 17:20:13 | 18,000 0 |
18,000 | Form 4 |
29 | Dybbs Michael Director |
2025-04-11 16:59:26 | 18,000 0 |
18,000 | Form 4 |
30 | PATEL SAMIR CHANDRAKANT Director |
2025-04-11 17:04:19 | 18,000 0 |
18,000 | Form 4 |
31 | Jovan-Embiricos Morana Director |
2025-04-11 17:08:35 | 18,000 0 |
18,000 | Form 4 |